News

Volcanic microbes under the microscope: Scientists identify optimal DNA extraction method
A research team from Skoltech, the Institute of Physical, Chemical, and Biological Problems of Soil Science of the Russian Academy of Sciences, and other scientific organizations in Russia and the U.S ...
Ophthalmology Times1d
Ocugen’s IND amendment to begin phase 2/3 confirmatory trial of OCU410ST cleared by FDA
Ocugen has announced the US Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) amendment to ...
Ocugen, Inc. Announces U.S. FDA Clearance Of Investigational New Drug Amendment To Initiate Phase 2/3 Pivotal Confirmatory Clinical Trial Of OCU410ST-Modifier Gene Therapy ...
The OCU410ST Phase 2/3 pivotal confirmatory trial represents a major advancement as Ocugen's second late-stage clinical program. Ocugen plans to submit a BLA for OCU410ST in 2027 in alignment with its ...